Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation.

Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation. A 30-Year Follow-Up Study -- Jahangir et al., 10.1161/CIRCULATIONAHA.106.644484 -- Circulation
Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation. A 30-Year Follow-Up Study Arshad Jahangir MD, Victor Lee MBBS, Paul A. Friedman MD*, Jane M. Trusty RN, David O. Hodge MS, Stephen L. Kopecky MD, Douglas L. Packer MD, Stephen C. Hammill MD, Win-Kuang Shen MD, and Bernard J. Gersh MBChB, DPhil
From the Divisions of Cardiovascular Diseases (A.J., V.L., P.A.F., J.M.T., S.L.K., D.L.P., S.C.H., W.-K.S., B.J.G.) and Biostatistics (D.O.H.), Mayo Clinic, Rochester, Minn.
* To whom correspondence should be addressed. E-mail: friedman.paul@mayo.edu
.
Background--The long-term natural history of lone atrial fibrillation is unknown. Our objective was to determine the rate and predictors of progression from paroxysmal to permanent atrial fibrillation over 30 years and the long-term risk of heart failure, thromboembolism, and death compared with a control population.
Methods and Results--A previously characterized Olmsted County, Minnesota, population with first episode of documented atrial fibrillation between 1950 and 1980 and no concomitant heart disease or hypertension was followed up long term. Of this unique cohort, 76 patients with paroxysmal (n=34), persistent (n=37), or permanent (n=5) lone atrial fibrillation at initial diagnosis met inclusion criteria (mean age at diagnosis, 44.2±11.7 years; male, 78%). Mean duration of follow-up was 25.2±9.5 years. Of 71 patients with paroxysmal or persistent atrial fibrillation, 22 had progression to permanent atrial fibrillation. Overall survival of the 76 patients with lone atrial fibrillation was 92% and 68% at 15 and 30 years, respectively, similar to 86% and 57% survival for the age- and sex-matched Minnesota population. Observed survival free of heart failure was slightly worse than expected (P=0.051). Risk for stroke or transient ischemic attack was similar to the expected population risk during the initial 25 years of follow-up but increased thereafter (P=0.004), although CIs were wide. All patients who had a cerebrovascular event had developed 1 risk factor for thromboembolism.
Conclusions--Comorbidities significantly modulate progression and complications of atrial fibrillation. Age or development of hypertension increases thromboembolic risk.